Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−25 JPY
−1.13 B JPY
316.82 M JPY
14.03 M
About NOILE-IMMUNE BIOTECH INC
Sector
Headquarters
Tokyo
Founded
2015
Website
ISIN
JP3759560000
FIGI
BBG01FKBX2N2
Noile-Immune Biotech, Inc. is a biotech company. It engages in the development of CAR-T cell therapy, a cancer immunotherapy for solid tumors using proprietary technology. The company was founded on April 16, 2015 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4893 is 158 JPY — it has increased by 0.64% in the past 24 hours. Watch NOILE-IMMUNE BIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange NOILE-IMMUNE BIOTECH INC stocks are traded under the ticker 4893.
4893 stock has fallen by −3.07% compared to the previous week, the month change is a −9.71% fall, over the last year NOILE-IMMUNE BIOTECH INC has showed a −22.93% decrease.
4893 reached its all-time high on Jun 28, 2023 with the price of 775 JPY, and its all-time low was 121 JPY and was reached on May 30, 2024. View more price dynamics on 4893 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4893 stock is 1.28% volatile and has beta coefficient of 1.78. Track NOILE-IMMUNE BIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is NOILE-IMMUNE BIOTECH INC there?
Today NOILE-IMMUNE BIOTECH INC has the market capitalization of 6.79 B, it has decreased by −7.14% over the last week.
Yes, you can track NOILE-IMMUNE BIOTECH INC financials in yearly and quarterly reports right on TradingView.
NOILE-IMMUNE BIOTECH INC is going to release the next earnings report on Feb 18, 2025. Keep track of upcoming events with our Earnings Calendar.
4893 earnings for the last quarter are −2.39 JPY per share, whereas the estimation was 15.79 JPY resulting in a −115.14% surprise. The estimated earnings for the next quarter are −20.87 JPY per share. See more details about NOILE-IMMUNE BIOTECH INC earnings.
NOILE-IMMUNE BIOTECH INC revenue for the last quarter amounts to 3.00 M JPY, despite the estimated figure of 2.61 M JPY. In the next quarter, revenue is expected to reach 313.80 M JPY.
4893 net income for the last quarter is −103.67 M JPY, while the quarter before that showed −343.24 M JPY of net income which accounts for 69.80% change. Track more NOILE-IMMUNE BIOTECH INC financial stats to get the full picture.
No, 4893 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 28.00 employees. See our rating of the largest employees — is NOILE-IMMUNE BIOTECH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOILE-IMMUNE BIOTECH INC EBITDA is −1.17 B JPY, and current EBITDA margin is −244.74%. See more stats in NOILE-IMMUNE BIOTECH INC financial statements.
Like other stocks, 4893 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOILE-IMMUNE BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOILE-IMMUNE BIOTECH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOILE-IMMUNE BIOTECH INC stock shows the strong sell signal. See more of NOILE-IMMUNE BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.